Vaccine News and Research

Latest Vaccine News and Research

Persistent TB infection of macrophages puts the brakes on immune engines, study shows

Scientists from Trinity College Dublin have discovered both how TB puts the brakes on our immune engines and how we can kick-start those engines back into gear - providing hope that improved treatment options could soon be on the horizon.

8 Jan 2020

Growing influenza vaccines inside chicken eggs can make them less effective, say some experts

Flu season is underway in the Northern Hemisphere, sickening millions of people and in rare cases, causing hospitalization or death. The best prevention is a flu shot, but it's not unusual for these vaccines to be less effective than intended. Some researchers suspect that the common practice of producing vaccines in chicken eggs could be partially to blame, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.

8 Jan 2020

New study characterizes how Twitter users discuss miscarriage, preterm birth

A new Boston University School of Public Health study characterizes how Twitter users discuss miscarriage and preterm birth. Published in Paediatric and Perinatal Epidemiology, the study finds that miscarriage disclosures by Michelle Obama and other public figures prompted spikes in discussion, and in other people sharing their own experiences of miscarriage.

8 Jan 2020

The WHO calls for more funding to help curb world’s worst measles outbreak

The WHO is calling for more funding to curb the world’s worst outbreak of measles, as the death toll in DRC reaches over 6000.

8 Jan 2020

NYU Langone Health announces launch of a multidisciplinary Vaccine Center

Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.

7 Jan 2020

Novel nanoparticle vaccine provides long-lasting protection against influenza virus

A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.

7 Jan 2020

Study shows the difficulty to undo damage caused by HPV vaccine misinformation

The number of girls receiving HPV vaccines in Denmark plummeted after vaccine misinformation spread through Danish media outlets from 2013 to 2016. Health officials launched a campaign in 2017 aiming to correct the misinformation and encourage girls to get vaccinated.

7 Jan 2020

Single dose of antibody-based treatment can beat HIV in newborn babies

A single dose of an antibody-based treatment can prevent HIV transmission from mother to baby, new nonhuman primate research suggests for the first time. The findings are being published in the journal Nature Communications.

7 Jan 2020

Can FDA-approved flu shots be repurposed as treatments for cancer?

Changing the microenvironment of tumors to increase the immune system's response to them has been the goal of countless research and clinical studies including the most recent use of checkpoint inhibitory antibodies.

7 Jan 2020

ART may not be completely effective in restoring immune protection, study suggests

A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy, antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.

6 Jan 2020

CDC warns that current flu season is due to be particularly long and severe

The current flu season is on track to be one of the most severe in years, according to new data from the CDC.

6 Jan 2020

Researchers study new immunogenic properties of already existing anti-cancer drugs

The world scientific community is waging a difficult and prolonged war on cancer. New research in the field of immunogenic cell death can extend the area of drugs application and ensure patients' protection from relapse after therapy.

3 Jan 2020

Intravenous BCG vaccine provides greater protection against tuberculosis

Researchers have found that the BCG vaccine is more efficacious in the prevention of TB when administered intravenously.

2 Jan 2020

GlobalData: Asia-Pacific seasonal influenza vaccine market set to reach US$1bn by 2028

The size of the seasonal influenza vaccine market across the three major Asia-Pacific (APAC) growth markets (3GM) will grow at a modest compound annual growth rate (CAGR) of 1.4% from US$914m in 2018 to US$1.05bn in 2028, says GlobalData, a leading data and analytics company.

2 Jan 2020

Intravenous administration boosts protective power of TB vaccine

Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated.

2 Jan 2020

New dementia vaccine may proceed to clinical trials after successful testing

A preventive treatment for dementia may proceed to clinical trials after successful animal testing.

31 Dec 2019

One dose of HPV vaccine may prevent infection from cancer-causing virus, study reveals

A new study revealed that one dose of the HPV vaccine may prevent infection from the potential cancer-causing virus, according to research published in JAMA Network Open from The University of Texas Health Science Center at Houston.

28 Dec 2019

Study helps explain why previous attempts to develop a staph vaccine have failed

Staph bacteria, the leading cause of potentially dangerous skin infections, are most feared for the drug-resistant strains that have become a serious threat to public health.

26 Dec 2019

CD4 T cells are not to be blamed for pushing dengue fever from bad to worse

No one knows what makes a mild dengue viral infection morph into a severe and sometimes deadly dengue hemorrhagic fever/dengue shock syndrome.

26 Dec 2019

California's vaccine policy improved immunization coverage

In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.

23 Dec 2019